Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.00 Million ≈ $12.88 Million USD) by net assets (CN¥4.13 Billion ≈ $603.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Guangdong Zhongsheng Pharmaceutical Co L to measure how much of total assets are equity-financed.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Guangdong Zhongsheng Pharmaceutical Co L to evaluate the quality of earnings relative to operating cash generation.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inner Mongolia Yuan Xing Energy Co Ltd
SHE:000683
|
0.087x |
|
Zhejiang Lante Optics Co Ltd
SHG:688127
|
0.080x |
|
Minmetals Capital Co Ltd
SHG:600390
|
0.066x |
|
Beijing Easpring Material Tech
SHE:300073
|
0.022x |
|
Chenzhou Jingui Silver Industry Co Ltd
SHE:002716
|
0.008x |
|
Amedisys Inc
NASDAQ:AMED
|
0.053x |
|
Kinaxis Inc
TO:KXS
|
0.148x |
|
Trigano S.A.
PA:TRI
|
0.204x |
Annual Cash Flow Conversion Efficiency for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Guangdong Zhongsheng Pharmaceutical Co L.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.01 Billion ≈ $586.81 Million |
CN¥337.84 Million ≈ $49.44 Million |
0.084x | +100.03% |
| 2023-12-31 | CN¥4.53 Billion ≈ $662.25 Million |
CN¥190.61 Million ≈ $27.89 Million |
0.042x | +154.87% |
| 2022-12-31 | CN¥3.82 Billion ≈ $558.47 Million |
CN¥63.07 Million ≈ $9.23 Million |
0.017x | -90.61% |
| 2021-12-31 | CN¥3.54 Billion ≈ $517.74 Million |
CN¥622.77 Million ≈ $91.13 Million |
0.176x | +359.44% |
| 2020-12-31 | CN¥3.63 Billion ≈ $530.67 Million |
CN¥138.93 Million ≈ $20.33 Million |
0.038x | -36.93% |
| 2019-12-31 | CN¥4.13 Billion ≈ $605.00 Million |
CN¥251.16 Million ≈ $36.75 Million |
0.061x | -26.56% |
| 2018-12-31 | CN¥3.95 Billion ≈ $578.14 Million |
CN¥326.78 Million ≈ $47.82 Million |
0.083x | -16.59% |
| 2017-12-31 | CN¥3.73 Billion ≈ $545.87 Million |
CN¥369.91 Million ≈ $54.13 Million |
0.099x | +0.37% |
| 2016-12-31 | CN¥3.42 Billion ≈ $501.07 Million |
CN¥338.28 Million ≈ $49.50 Million |
0.099x | +8.41% |
| 2015-12-31 | CN¥2.11 Billion ≈ $308.69 Million |
CN¥192.25 Million ≈ $28.13 Million |
0.091x | +72.01% |
| 2014-12-31 | CN¥1.90 Billion ≈ $277.85 Million |
CN¥100.60 Million ≈ $14.72 Million |
0.053x | -16.77% |
| 2013-12-31 | CN¥1.74 Billion ≈ $255.05 Million |
CN¥110.95 Million ≈ $16.23 Million |
0.064x | -29.06% |
| 2012-12-31 | CN¥1.59 Billion ≈ $232.18 Million |
CN¥142.38 Million ≈ $20.83 Million |
0.090x | +87.87% |
| 2011-12-31 | CN¥1.48 Billion ≈ $216.16 Million |
CN¥70.56 Million ≈ $10.32 Million |
0.048x | -27.79% |
| 2010-12-31 | CN¥1.39 Billion ≈ $202.91 Million |
CN¥91.72 Million ≈ $13.42 Million |
0.066x | -15.09% |
| 2009-12-31 | CN¥1.30 Billion ≈ $189.52 Million |
CN¥100.89 Million ≈ $14.76 Million |
0.078x | -81.57% |
| 2008-12-31 | CN¥172.40 Million ≈ $25.23 Million |
CN¥72.86 Million ≈ $10.66 Million |
0.423x | +11.80% |
| 2007-12-31 | CN¥130.56 Million ≈ $19.11 Million |
CN¥49.35 Million ≈ $7.22 Million |
0.378x | +192.84% |
| 2006-12-31 | CN¥138.72 Million ≈ $20.30 Million |
CN¥17.91 Million ≈ $2.62 Million |
0.129x | -- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.